extremely significantP < 0.001
In contrast, the group treated with silymarin showed extremely significant ( P < 0.001) decreases in direct bilirubin, SGOT, SGPT and ALP values toward normalization.
In contrast, the group treated with silymarin showed extremely significant ( P < 0.001) decreases in direct bilirubin, SGOT, SGPT and ALP values toward normalization.